Orgenesis Inc. (NASDAQ:ORGS – Get Free Report)’s stock price fell 13.1% on Friday . The company traded as low as $1.39 and last traded at $1.39. 3,112 shares traded hands during trading, a decline of 63% from the average session volume of 8,511 shares. The stock had previously closed at $1.60.
Orgenesis Stock Performance
The firm has a 50 day moving average price of $1.45.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
See Also
- Five stocks we like better than Orgenesis
- How to Effectively Use the MarketBeat Ratings Screener
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 3 REITs to Buy and Hold for the Long Term
- Oilfield Leader SLB: An AI Name You Need to Know
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
